Sub-Speciality Societies/National Societies/Specialized Societies
Sub-Speciality Societies Meetings may be held during the Congress. Societies are kindly requested to contact the Scientific Secretariat at president@EADVVienna2007.com for further arrangements.
Delegates attending a Sub-Speciality Societies Meeting as well as Speakers of a Sub-Speciality Societies Session have to register for the Congress.
Members, Non-Member and Speakers of the Sub-Speciality Societies Meetings are not entitled to a free registration.
Wednesday, 16 May 2007
SSS1 Dermatology and Human Rights (CDI)
08.00-12.00 Hall F2
Chair: A. Morrone (Rome, Italy), B. Naafs (Leiden, Netherlands), T. Ryan (Oxford, UK)
| 8.00 | Welcome and Opening remarks. A. Morrone (Rome, Italy), B. Naafs (Leiden, Netherlands), T. Ryan (Oxford, UK) | |
| 8.00 | SSS1.1 | CDI: timely but what purpose? T. Ryan (Oxford, UK) |
| 8.15 | SSS1.2 | Dermatology and Human Rights: our experience in Ethiopia. A. Morrone (Rome, Italy) |
| 8.30 | SSS1.3 | Leprosy: the consequence of its elimination. B. Naafs (Leiden, Netherlands) |
| 8.45 | SSS1.4 | Community Dermatology in Guerrero Mexico. R. Estrada (Acapulco, Mexico) |
| 9.00 | SSS1.5 | ISD Programme for developing countries: an update. T. Lotti (Florence, Italy) |
| 9.15 | SSS1.6 | Pitfalls of practice of dermatology in the developing world. S. Verma (Vadodara, India) |
| 9.30 | SSS1.7 | Education and training of Community Health Workers in Dermatology. P. Buxton (Southampton, UK) |
| 9.45 | SSS1.8 | Mycetomas in Guerrero Mexico. L. Chavez (Acapulco, Mexico) |
| 10.00 | SSS1.9 | Tattoo and piercing between North and South. C. Gelmetti (Milan, Italy) |
| 10.15 | SSS1.10 | Vitiligo in black and white skin. M. Picardo (Rome, Italy) |
| 10.30 | SSS1.11 | Rare autoimmunity skin diseases among immigrants, M. Carducci (Rome, Italy) |
| 10.45 | SSS1.12 | Health and globalisation-where should dermatology stand? R. Hay (Belfast, UK) |
| 11.00 | SSS1.13 | Immunoreconstitution in AIDS patients. L. Valenzano (Rome, Italy) |
| 11.15 | SSS1.14 | Skin neoplasm in Ethiopia. A. Amantea (Rome, Italy) |
| 11.30 | SSS1.15 | Infestations due to helminths of dermatological interest. S. Veraldi (Milan, Italy) |
| 11.45 | SSS1.16 | Ethical aspects of cutaneous tests. E. Berardesca (Rome, Italy) |
| 12.00 | Closing remarks A. Morrone (Rome, Italy), B. Naafs (Leiden, Netherlands), T. Ryan (Oxford, UK) |
SSS11 Sister Society Meeting of the European Society for Pediatric Dermatology
08.00 – 11.00 Hall J241
Chair: R. Happle (Marburg, Germany), P. Hoeger (Hamburg, Germany), R. Grimalt (Barcelona, Spain), Zs. Szalai (Budapest, Hungary)
| 8.00 | Session I | |
| 8.00 | SSS11.1 | Atypical neurofibromatosis as a contiguous gene syndrome. B. Binder (Graz, Austria) |
| 8.08 | SSS11.2 | Autoimmune Diseases Associated with Neurofibromatosis Type 1 (NF1): Coincidence or a Causal Link. A. Nanda (Salmiya, Kuwait) |
| 8.16 | SSS11.3 | Research project on skin pigmented lesions in paediatric age. N. Balato (Naples, Italy) |
| 8.24 | SSS11.4 | IIdiopathic photodermatoses in childhood. I. Horkay (Debrecen, Hungary) |
| 8.32 | SSS11.5 | An interesting case of Netherton syndrome. L. Mervic (Ljubljana, Slovenia) |
| 8.40 | SSS11.6 | The first two cases of ichthyosis prematurity syndrome in Denmark. Presentation of clinical and ultrastructural findings. A. Bygum (Odense, Denmark) |
| 8.48 | SSS11.7 | Pansclerotic morphea in children. U. Wollina (Dresden, Germany) |
| 9.00 | Session II | |
| 9.00 | SSS11.8 | Embolia cutis medicamentosa (Nicolau Syndrome) in children: Case report and review of the literature. P. Hoeger, A. Kienast (Hamburg, Germany) |
| 9.08 | SSS11.9 | Non Langerhans cell histiocytosis presenting clinically as Langerhans cell histiocytosis. P. Ponte, J. Baptista, I. Viana, E. Vale, T. Fiadeiro (Lisbon, Portugal) |
| 9.16 | SSS11.10 | A newborn with fatal systemic juvenile xanthogranuloma and bone marrow aplasia. A. Torrelo, A. Hernández (Madrid, Spain) |
| 9.24 | SSS11.11 | Experience with imiquimod in childhood haemangioma. C. McCuaig (Montreal, Canada) |
| 9.32 | SSS11.12 | Cutaneaous tuberculosis in children in Tunis. M. Kharfi, N. El Fekih, A. Khaled, M.R. Kamoun (Tunis, Tunisia) |
| 9.40 | SSS11.13 | Pustulosis acuta generalisata in a child. A. Patrizi (Bologna, Italy) |
| 9.48 | SSS11.14 | Cutaneous leishmaniasis from the Mediterranean. J. Pace (Msida, Malta) |
| 10.00 | Board Meeting | |
SSS5 European Society for Cosmetic and Aesthetic Dermatology at the 16th EADV Congress – in association with International Academy of Cosmetic Dermatology
08.30 – 18.20 Hall C
President of ESCAD: A. Katsambas (Athens, Greece)
President of IACD: L.C. Parish (Philadelphia, USA)
| 8.30 | ESCAD Executive Board meeting (ESCAD Executive Board members) A. Katsambas (Greece) | |
| 9.00 | Brief Communications (All EADV registrants welcome) Chairs: C.Rowland-Payne (London, UK), A. Katsambas (Athens, Greece), L. Millikan (New Orleans, USA) | |
| 9.00 | Welcome to ESCAD Scientific Meeting. A. Katsambas (Athens, Greece) | |
| 9.05 | SSS5.1 | NutriPeel ABH. H. Zelenkova (Bratislava, Slovakia) |
| 9.10 | SSS5.2 | Combined peeling is safe. A.M. Amer (Cairo, Egypt) |
| 9.15 | SSS5.3 | Difficulty in melasma treatment in Middle Eastern people. C. Chams (Tehran, Iran) |
| 9.20 | SSS5.4 | Melatonin, a new cosmeceutical. M.Amer (Cairo, Egypt) |
| 9.25 | SSS5.5 | Topical antioxidants – new observations. S.R. Pinnell (Durham, USA) |
| 9.30 | SSS5.6 | Cosmetic surgery for vitiligo patches. T. Lotti (Florence,Italy) |
| 9.35 | SSS5.7 | Mosaic subclinical melanoderma and skin cancers. P. Quatresooz (Belgium) |
| 9.40 | SSS5.8 | Cosmetic pearls from Mexico. E. Welsh (Mexico) |
| 9.45 | SSS5.9 | Skin care and cosmeceuticals. J. Gray (UK) |
| 9.50 | SSS5.10 | Can a topically applied cosmetic modify skin relief and reduce wrinkles? P. Humbert (Besançon, France) |
| 9.55 | SSS5.11 | Active ingredients in cosmetic preparations, what is true about them? M. Malek (Amman, Jordan) |
| 10.00 | SSS5.12 | Anti-ageing creams: hope or hype? T. Griffiths (Manchester, UK) |
| 10.05 | SSS5.13 | Systemic and topical antioxidants for prevention of skin ageing. L. Polla (Geneva, Switzerland) |
| 10.10 | SSS5.14 | The combination of laser and liposuction to improve the lower face and neck. U. Wollina (Dresden, Germany) |
| 10.15 | SSS5.15 | Update on microsclerotherapy. M. Neumann (Rotterdam, Netherlands) |
| 10.20 | SSS5.16 | Organising your practice: something you never thought to be so important. L. Marini (Trieste, Italy) |
| 10.25 | Q&A | |
| 11.00 | Hot Topic I: The lipolysis controversy – a balloon debate Chairs: P. Andre (Paris, France), N. Benedetto (Philadelphia, USA), E. Haneke (Freiburg, Germany) | |
| 11.00 | SSS5.17a | Injection lipolysis: just hot air?. D. Kopera (Graz, Austria) |
| 11.05 | SSS5.17b | Injection lipolysis: ad astra? L. Habbem (Bossum, Netherlands) |
| 11.10 | General debate | |
| 11.15 | The ESCAD Presidential Address Chairs: C. Chams (Tehran, Iran), P. Humbert (Besançon, France), Y. Yazan (Istanbul, Turkey) | |
| 11.15 | SSS5.18 | Melasma: What’s new in treatment. A. Katsambas (Athens, Greece) |
| 11.35 | Q&A | |
| 11.45 | State of the Art: Pigmentation - Treatment Chairs: E. Berardesca (Italy), P. Humbert (Besançon, France), B. Walkiewicz-Crysanska (Warsaw, Poland) | |
| 11.45 | SSS5.19 | What’s new in the cosmetic treatment of hyperpigmentation? G. Gulielmini, E. Berardesca (Italy) |
| 12.00 | SSS5.20 | Avoiding trouble when treating darker skins. M. Sachdev (India) |
| 12.15 | Q&A | |
| 12.30 | Keynote Address Chairs: C. Diericx (Antwerp, Belgium), E. Ozunturk (Istanbul, Turkey), L. Polla (Geneva, Switzerland) | |
| 12.30 | SSS5.21 | Infrared skin tightening (Titan). E. Battle (Washington, USA) |
| 12.50 | Q&A | |
| 13.00 | Hair Today, Hair Tomorrow Chairs: C. Gho (Amsterdam, Netherlands), M. Neumann (Rotterdam, Netherlands), H. Zelenkova (Bratislava, Slovakia) | |
| 13.00 | SSS5.22 | Stem cell hair transplantation. C. Gho (Netherlands), C. Rowland-Payne (UK) |
| 13.15 | SSS5.23 | Hair transplants. A. Ginsburg (Raanana, Israel) |
| 13.30 | Round table discussion | |
| 13.45 | Update on Second Generation Intense Pulsed Light (I2PL) Chairs: D. Kopera (Graz, Austria), K. Nouri (Miami, USA), S. Lanigan (Birmingham, UK) | |
| 13.45 | SSS5.24 | Collagen remodelling with I2PL. P. Bjerring (Aarhus, Denmark) |
| 14.00 | SSS5.25 | Treatment of hidradenitis suppurativa with I2PL. A. Troilius (Malmö, Sweden) |
| 14.15 | SSS5.26 | Treatment of haemangioma with I2PL. M. Drosner (Munich, Germany) |
| 14.30 | Q&A | |
| 14.45 | Hot Topic II: Ultrasound liposuction Chairs: J. Hercogova (Prague, Czech Republic), L. Marini (Trieste, Italy), L. Polla (Geneva, Switzerland) | |
| 14.45 | SSS5.27 | Non-invasive liposuction by ultrasound. J. Hercogova (Prague, Czech Republic) |
| 14.50 | SSS5.28 | UltraShape ultrasound liposuction. L. Polla (Geneva, Switzerland) |
| 15.15 | Q&A | |
| 15.30 | Update on Botulinum, Fillers & Peels Chairs: D. Grablowitz (Vienna, Austria), O. Kreyden (Basel, Switzerland), B. Rzany (Berlin, Germany), L. Wiest (Munich, Germany) | |
| 15.30 | SSS5.29 | Radio frequency combined with botulinum. M. Malek (Amman, Jordan) |
| 15.45 | SSS5.30 | Advanced BTX therapy for hyperhidrosis. O. Kreyden (Basel, Switzerland) |
| 16.00 | SSS5.31 | Earlobe rejuvenation using crosslinked hyaluronic acid. E. Monteiro (Sao Paulo, Brazil) |
| 16.15 | SSS5.32 | Deep chemical peeling vs facelift – can a deep peel spare the need for surgery? I. Verner (Israel) |
| 16.30 | Round table discussion | |
| 16.45 | What’s New in Cosmetic Dermatology Chairs: A. Camps-Fresneda (Barcelona, Spain), C. Rowland-Payne (London, UK), U. Wollina (Dresden, Germany) | |
| 16.45 | SSS5.33 | What’s new in botulinum toxin A? B. Rzany (Berlin, Germany) |
| 17.00 | SSS5.34 | What’s new in cosmetic laser dermatology? S. Lanigan (Birmingham, UK) |
| 17.15 | SSS5.35 | What’s new in minimally invasive injection cosmetic dermatology? P. Velthuis (Rotterdam, Netherlands) |
| 17.30 | SSS5.36 | What’s new in liposuction? L Habbema (Bossum, Netherlands) |
| 17.45 | SSS5.37 | What’s new in cosmetic dermatological surgery? E. Haneke (Freiburg, Germany) |
| 18.00 | Close of ESCAD scientific meeting C. Rowland-Payne (London, UK) | |
| 18.00 | ESCAD Annual General Meeting (All ESCAD Members welcome) A. Camps-Fresneda (Barcelona, Spain) | |
| 18.20 | Close of ESCAD AGM | |
SSS8 How to Improve Laser and Light Source Treatments in Dermatology: Theoretical and Practical Progress (ESLD)
08.30 – 18.00 Hall H
Learning objectives:
Following this meeting, the attendee will be able to:
- understand the past and present theoretical basis of modern laser dermatology
- have knowledge of progressive evolution of laser and polychromatic light treatments presently used in dermatology
- choose the appropriate photo-thermal strategies to effectively treat commonly encountered problems in a modern dermatological-surgical practice
Description:
This meeting will help attendees update their knowledge in photo-thermal treatments presently used in modern dermatologic surgery. Their evaluation and management of patients affected by dermatological problems suitable to be treated by lasers and polychromatic light sources will be positively influenced by presentations on treatment strategies using old and new approaches. Knowledge of basic laser and polychromatic light principles as well as their technical evolution will be of great help in taking full advantage of this teaching experience. Practical evaluations and management tips will be discussed by chairpersons at the end of each main session. This meeting is addressed to the practising clinician with specific interests in dermatological laser treatments.
| 9.30 - 10.00 | ELSD Board Meeting | |||
| 10.00 - 10.30 | ESLD OGM (ESLD Members only) | |||
| 10.30 - 13.15 | ESLD Annual Scientific Meeting- Part A. & B . Open to all EADV Congress participants/ ESLD members free / ESLD non-members €50 | |||
| A. Vascular lesions, Rosacea, Scars. Chairs: M. Adatto (Geneva, Switzerland), A. Troilius (Malmö, Sweden), M. Hædersdal (Copenhagen, Denmark) | ||||
| 10.30 | SSS8.A1 | Laser and light treatments for acne and acne-like dermatosis. M. Hædersdal(Copenhagen, Denmark) | ||
| 10.42 | SSS8.A2 | Treatment of proliferating haemangioma with laser and IPL – a retrospective study. A.Troilius, E. Irestedt (Sweden) | ||
| 10.54 | SSS8.A3 | Treatment of papulopustular rosacea with pulsed dye laser. S. Fallah-Arani, H.A.M.Neumann (The Netherlands) | ||
| 11.06 | SSS8.A4 | Update: PDL Treatment of Scars. – K. Nouri, A. R. Patel (USA) | ||
| 11.16 | SSS8.A5 | Variable-long-pulse Nd:YAG Laser For the treatment of rosacea and facial telangiectasia. A four year experience A. Campo-Voegeli (Spain) | ||
| 11.26 | SSS8.A6 | Treatment of acne vulgaris with a photo-pneumatic pixilation (PPx)™ vacuum enhanced light source K. Fritz (Landau, Germany) | ||
| 11.36 | Discussion & Coffee Break | |||
|
B. Facial and Non- Facial Skin Rejuvenation - Ablative, Fractional, Non Ablative | ||||
| 11.50 | SSS8.B1 | Fractional photothermolysis: My point of view. D. Manstein (Boston, USA) | ||
| 12.10 | SSS8.B3 | Fractionated laser technology for skin rejuvenation – S. Lanigan (UK) | ||
| 12.25 | SSS8.B3 | Ultrapulsed CO2 laser for treatment of actinic cheilitis. K. Nouri, A.R. Patel (USA) | ||
| 12.35 | SSS8.B4 | Photodynamic photorejuvenation, an update. P. Bjerring (Vejle, Denmark) | ||
| 12.45 | SSS8.B5 | Comparison of different pulse durations in photo rejuvenation treatment of lentigines with an intense pulsed light source. M. Drosner, A. Olbing (Germany) | ||
| 12.55 | SSS8.B6 | A novel device for fractional resurfacing without anaesthesia. D. Cassato (Italy) | ||
| 13.05 | Discussion & Snack Break | |||
| 13.15 - 13.45 | Lunch | |||
| 13.45 - 15.00 | Industry Member session , supported by companies (limited to Industry Members of ESLD). Open to all participants to EADV Congress/ Free access. Chairs: M. Adatto (Geneva, Switzerland), K. Fritz (Landau, Germany), M. Lapidoth (Petah Tikva, Israel) | |||
| 15.00 - 17.30 |
ESLD Annual Scientific Meeting – Part C. - E. Open to all EADV Congress participants/ ESLD members free / ESLD non-members €50.- | |||
|
C. Body shaping and skin tightening | ||||
| 15.00 | SSS8.C1 | Lasers for skin tightening, body shaping and cellulite management – new tools for the laser surgeon. M. Gold (Nashville, USA) | ||
| 15.20 | SSS8.C2 | Skin tightening devices. C. Dierickx (Boom, Belgium) | ||
| 15.35 | SSS8.C3 | Electo-optical body shaping - a practical guide. M. Lapidoth (Petah Tikva, Israel) | ||
| 15.50 | SSS8.C4 | Combination of unipolar and bipolar radiofrequency for cellulite improvement: A preliminary report. M. Adatto (Geneva, Switzerland) | ||
| 15.57 | Q&A | |||
|
D. New indications and general topics | ||||
| 16.10 | SSS8.D1 | Comparative study between the Excimer laser and PDL in treatment of psoriasis. A. Badawi (Egypt) | ||
| 16.17 | SSS8.D2 | Onychomycosis: An effective treatment using Dye Laser and IPL(580nm). How the method works. C. Demetriou (Cyprus) | ||
| 16.24 | SSS8.D3 | Intense Pulsed Light (IPL) Devices: Are claimed output parameters valid? G. Town (UK) | ||
| 16.31 | SSS8.D4 | Side effects and complications using Intense Pulsed light sources (IPL). S. Stangl, W. Kimmig (Germany) | ||
|
E. Free communications | ||||
| 16.40 | SSS8.E1 | Infra red flashlamp and radiofrequency current for skin tighteninig. M. Pelletier (France) | ||
| 16.47 | SSS8.E2 | Striae Improvement with a new infrared pulsed lamp: A preliminary Study. M. Adatto (Switzerland), J.L. Levy (France) | ||
| 16.54 | SSS8.E3 | Appliance of polarized light therapy (480-3400nm) in the dermatology. J. Begić-Rahić (Bosnia and Hercegovina) | ||
| 17.01 | SSS8.E4 | Histological and ultrastructural evidence of pilosebaceous unit thermal injury during the treatment of acne using photopneumatic (PPX) therapy. T. Omi, S. Kawana, S. Sato (Japan) | ||
| 17.08 | SSS8.E5 | Nonablative 1450-nm diode laser in the treatment of facial atrophic acne scars in dark skin types: A prospective clinical study. S. Ghannam (Kuwait) | ||
| 17.15 | SSS8.E6 | Scars: classification and treatment mistakes. O. Bogomolets, (Ukraine) | ||
| 17.22 | Discussion & Conclusion | |||
SSS10 European Skin-care Nursing Network - 9th Annual Conference
8.30 – 18.00 Hall O
Chair: B. Page (Dunfermline, UK)
| 10.00 | Welcome to Vienna and introduction. B. Page (UK) | |
| 10.30 | SSS10.1 | Chemical weapons: brief history and most known weapons responsible for skin damage. A. Bicchi (Italy) |
| 11.00 | Coffee break | |
| 11.30 | SSS10.2 | Wound care link nurses: an essential role of the tissue viability service. E. Gibson (UK) |
| 12.00 | SSS10.3 | Photonet and phototherapist training programme. A. Joy (UK) |
| 12.30 | ESNN Annual General Meeting | |
| 13.00 | Lunch | |
| 14.30 | SSS10.4 | Skincare nursing in Vienna. E. Kleyhons (Austria) |
| 15.00 | Hospital visit (TBC) | |
| 18.00 | Close |
SSS15 The Spectrum of Dermatological PDT (Euro PDT)
8.30 – 12.00 Room J565
Chairs: A. Sidoroff (Innsbruck, Austria), R.-M. Szeimies (Regensburg, Germany)
| 08.30 | Welcome. R.-M. Szeimies (Germany) | |
| 08.40 | SSS15.1 | Topical PDT – overview of licensed indications. N. Basset-Seguin (France) |
| 09.20 | SSS15.2 | PDT beyond cure rates – a critical appraisal. A. Sidoroff (Austria) |
| 09.50 | SSS15.3 | Practical issues of PDT: pearls, pain & side effects. T. Warloe (Norway) |
| 10.20 | Coffee break | |
| 11.00 | SSS15.4 | PDT for SCC – useful or not? P. Calzavara-Pinton (Italy) |
| 11.25 | SSS15.5 | PDT for psoriasis. S. Radakovic-Fijan (Austria) |
| 11.50 | SSS15.6 | PDT for other non-oncological indications. R.-M. Szeimies (Germany) |
| 12.15 | Closing remarks. A. Sidoroff (Austria) |
SSS18 The International League of Dermatological Societies Board Meeting
8.30 – 18.00 Hall A353
Chair: R. Marks (Melbourne, Australia)
SSS23 The University of Miami Experience (Miami Dermatological Society)
8.30 – 11.00 Hall F1
Chair: P. Romanelli (Miami, USA)
| SSS23.1 | A busy Miami dermatology practice. A. Pedrozo III (USA) |
| SSS23.2 | Novel immunohistochemistry stains in wound healing. M. Miteva (USA) |
| SSS23.3 | New syndromes in dermatopathology. P. Romanelli (USA) |
| SSS23.4 | Paediatric dermatology at the University of Miami. J. Izakovic (USA) |
| SSS23.5 | Ethnic skin. H. Woolery-Loyd (USA) |
| SSS23.6 | Update on facial resurfacing. K. Nouri (USA) |
| SSS23.7 | Treatment of keloids and scars. B. Berman (USA) |
| SSS23.8 | The future of dermatopharmacology. W.H.Eaglstein (USA) |
SSS25 Meeting of the Ukrainian Association of Dermatologists, Venereologists and Cosmetologists (UADVC)
12.30 – 14.30 Hall F2
Chair: V.G. Kolyadenko (Kiev, Ukraine)
| 12.30 | Introduction. V.G. Kolyadenko (Kiev, Ukraine) | |
| 12.35 | SSS25.1 | Epidemiologic tendencies of sexually transmitted infections including HIV in Ukraine and Western European countries. V.I. Stepanenko, V.G. Kolyadenko, P.V. Chernyshov (Kiev, Ukraine) |
| 12.45 | SSS25.2 | Medical consequences of Chernobyl accident (Ukraine, 1986). P.P. Ryzhko (Kharkov, Ukraine) |
| 12.55 | SSS25.3 | Current approaches of diagnostics and treatment of atopic dermatitis. L.D. Kaliuzhnaya (Kiev, Ukraine) |
| 13.05 | SSS25.4 | Peculiarities of skin diseases in HIV-positive patients. T.V. Protsenko, O.A. Protsenko (Donetsk, Ukraine) |
| 13.15 | SSS25.5 | Herpes Zoster. Current point of view. Yu.V. Andrashko (Uzhgorod, Ukraine) |
| 13.25 | SSS25.6 | Urogenital infections in patients with psoriatic arthritis. A.D. Dyudun, E.A. Saliy, N.N. Polion (Dnyepropetrovsk, Ukraine) |
| 13.35 | SSS25.7 | Current aspects of skin care in atopic dermatitis. O.V. Buyanova (Ivano-Frankivsk, Ukraine) |
| 13.45 | SSS25.8 | Clinical and immunological effects of probiotic lacidofil in infants with atopic dermatitis. P.V. Chernyshov (Kiev, Ukraine) |
| 13.55 | SSS25.9 | Treatment of pemphigus in Ukraine. K.V. Kolyadenko (Kiev, Ukraine) |
| 14.05 | SSS25.10 | Post-herpetic pain: senior patients’ management. A.G. Micheev (Kiev, Ukraine) |
| 14.15 | SSS25.11 | Peculiarities of the treatment of tinea pedis in patients with trophic ulcers. E.V. Ivanina (Kiev, Ukraine) |
| 14.20 | SSS25.12 | Herpes virus infection in dermatology. V.G. Kolyadenko (Kiev, Ukraine) |
SSS12 The European Surveillance System on Contact Allergies (ESSCA) - Current Results and Perspectives
09.00 – 12.00 Hall L
Chairs: A. Schnuch (Göttingen, Germany), W. Uter (Erlangen, Germany)
| 9.15 | Introduction. A. Schnuch, W. Uter (Erlangen, Germany) |
| 9.30 | Recent results from ESSCA, year 2004 |
| 10.00 | Patch test results from Barcelona, Spain, 2004-2006 and perspectives of the Spanish GEIDC network A. Gimenez-Arnau (Barcelona, Spain) |
| 10.30 | Software presentation of WinAlldat/ESSCA. W. Uter (Erlangen, Germany) |
| 11.00 | Discussion: Current research projects, proposals etc. |
SSS19 The International Psoriasis Council's Psoriasis Centers of Excellence Initiative
9.00 – 17.00 Hall A441
Chairs: R. Langley (Nova Scotia, Canada), A. Menter (Dallas, USA), J. Prinz (Munich, Germany)
SSS24 Dermatology in the Arab World: Past, Present and Future(PALD)
10.00 – 13.00 Hall M
Chair: M. Adib Batal
SSS6 Exciting Dermatopathology (ESDP)
10.30 – 14.00 Hall G
Chairs: G. Kaia (Geneva, Switzerland), C. Tomasini (Turin, Italy)
| 10.30 | Opening remarks | |
| 10.40 | International Board Certification in Dermatopathology 2006. H. Kerl (Graz, Austria) | |
| 11.00 | SSS6.1 | Clues for diagnosing paraproteinemia in skin biopsies. C. Tomasini (Turin, Italy) |
| 11.20 | SSS6.2 | Clinicopathologic correlation of melanocytic lesions. L. Cerroni (Graz, Austria) |
| 11.40 | SSS6.3 | Scalp radiotherapy for tinea capitis induces trichoblastic tumours. B. Cribier (Strasbourg, France), Becima Fazaa (Tunis, Tunisia) |
| 12.00 | SSS6.4 | Soft tissue tumours of the skin. A practical approach. G. Kaya (Geneva, Switzerland) |
| 12.20 | SSS6.5 | The histopathology of alopecia in transverse sections. C.M. Stefanato (London, UK) |
| 12.40 | SSS6.6 | A selection of more unusual skin cancers. R Cerio (London, UK) |
| 13.00 | SSS6.7 | New observations in granuloma annulare. B. Zelger (Innsbruck, Austria) |
| 13.20 | Closing remarks |
SSS4 Difficulties and Mistakes in Clinical Diagnosis (ENS)
11.00 – 15.00 Hall F1
| 11.00 | Welcome & Introduction. A. Tosti (Bologna, Italy) |
| 11.05 | Mistake session Chairs: A. Tosti (Bologna, Italy), R. Daniel (Jackson, USA) Speakers: E. Haneke (Freiburg, Germany), W. Robles (London, UK), B.M. Piraccini (Bologna, Italy), E. Duhard (Tours, France), N. Lateur (Brussels, Belgium) |
| 12.00 | General Meeting Chairs: A. Tosti (Bologna, Italy), M. Iorizzo (Bologna, Italy), N. Lateur (Brussels, Belgium) |
| 12.30 | Lunch break |
| 13.30 | Video surgery Chair: N. Lateur (Brussels, Belgium), D. deBerker (Bristol, UK) Speakers: B. Richert (Liege, Belgium), V. Blatiere (Montpellier, France) |
| 14.15 | Clinical cases difficult to diagnose Chairs: B.M. Piraccini (Bologna, Italy), E. Haneke (Freiburg, Germany) Speakers: O. Cogrel (Bordeaux, France), L. Castro (Sao Paulo, Brasil), D. deBerker (Bristol, UK) |
| 15.00 | Closing remarks. A. Tosti (Bologna, Italy) |
SSS17 Future directions of the IDS
12.00 – 14.00 Hall L
Chairs: H.P. Soyer (Graz, Austria), G. Argenziano (Naples, Italy)
The meeting will be an open space for discussion on the future directions of the IDS in regard to research and teaching.
Open Space is a way of organising a meeting so that there is maximum participation, energy and focus on the topic of discussion.
SSS22 Mayo Clinic Dermatology: The European Dimension
12.00 – 18.00 Hall J565
Chairs: F. Powell (Dublin, Ireland), R.S. Rogers (Rochester, USA)
European Associates of Mayo Clinic Dermatology:
| 13.00 | Welcome and Introduction to inaugural meeting of European Associates of Mayo Clinic Dermatology. R.S. Rogers III (USA) | |
| 13.15 | Research pearls Chairs: M. Pittelkow (USA), J.L. Diaz-Perez (Spain) | |
| 13.15 | SSS22.1 | KEYNOTE ADDRESS: The status of dermatological research in Europe. K. Wolff (Austria) |
| 13.45 | SSS22.2 | Dermatological research at Mayo Clinic. M. Pittelkow (USA) |
| 14.10 | SSS22.3 | Keratinocyte Biology: Is membrane cholesterol involved in epidermal control? Y. Poumay (France) |
| 14.30 | Clinical pearls from Europe Chairs: M. Meurer (Germany), S. Beuchner (Switzerland) | |
| 14.30 | SSS22.4 | New Treatment Options for Raynaud's Syndrome. M. Meurer (Germany) |
| 14.45 | SSS22.5 | Adverse Skin Reactions from Erlotinib. P. Cetovska |
| 15.00 | SSS22.6 | Recent Advances in Vitiligo. K. Schallreuter (UK) |
| 15.15 | Intermission | |
| 15.45 | Clinical pearls from the USA Chairs: L.E. Gibson (USA), R. elAzhary (USA) | |
| 15.45 | SSS22.7 | Hospital dermatology at Mayo Clinic. R.el-Azhary (USA) |
| 16.00 | SSS22.8 | Testing for immunobullous diseases. L.E. Gibson (USA) |
| 16.15 | Historical pearls Chairs: M. Davis (USA), A.N. Other (Europe) | |
| 16.30 | SSS22.9 | The history of dermatology at Mayo Clinic. M. Davis (USA) |
| 16.45 | SSS22.10 | Sister Mary Joseph and her Nodule. F.C. Powell (Ireland) |
| 16.45 | Closing Comments. F.C. Powell (Ireland), M. Meurer (Germany) | |
SSS16 European Society of Cutaneous Lupus Erythematosus (EUSCLE)
12.30 – 14.00 Hall J241
Chairs: A. Kuhn (Düsseldorf, Germany), F. Nyberg (Stockholm, Sweden)
| 12.30 | EUSCLE Annual Scientific Meeting |
| 13.30 | Case Discussions |
SSS3 Melanoma screening and detection – an Update (EADO)
15.00 – 18.00 Hall J241
Chairs: H. Pehamberger (Vienna, Austria); C. Garbe (Tübingen, Germany); J.J. Grob (Marseille, France)
| SSS3.1 | Introduction. Hubert Pehamberger (Vienna, Austria) |
| SSS3.2 | Outdoor workers – A potential risk for melanoma? R. Strohal (Austria) |
| SSS3.3 | Mass screen in melanoma – worthwhile? J.J. Grob (Marseille, France) |
| SSS3.4 | Screening of high risk groups. A. Stratigos (Athens, Greece) |
| SSS3.5 | Value of genetic testing- genotype and phenotype. K Peris (Italy) |
| SSS3.6 | Circulating melanoma cells. P. Arenberger (Prague, Czech Republic) |
| SSS3.7 | Computer-aided diagnosis of pigmented skin lesions. M. Binder (Vienna, Austria) |
| SSS3.8 | Dermoscopy in special locations. J. Malvehy (Spain) |
| SSS3.9 | Melanoma misdiagnosis – iImpact on prognosis. C. Garbe(Tübingen, Germany) |
| SSS3.10 | Follow-up of melanoma patients. A. Hauschild (Kiel, Germany) |
SSS13 7th Symposium of the European Task Force on Atopic Dermatitis / EADV Eczema Task Force
14.00 – 15.00 Hall M
Chairs: L. de Raeve (Brussels, Belgium), U. Darsow (Munich, Germany)
| 14.00 | SSS13.1 | Cerebral processing of histamine-induced itch with short term low intensity temperature modulation – an fMRI study. F. Pfab (Munich, Germany), M. Valet, T. Sprenger, T.R. Tölle, C. Zimmer, H. Behrendt, J. Ring, U. Darsow |
| 14.15 | SSS13.2 | Proliferation of skin-homing lymphocytes induced by the -Nascent polypeptide-associated complex (NAC, Hom S2) in Adult Patients with Atopic Dermatitis. A. Heratizadeh (Hannover, Germany), P. Kienlin, I. Mittermann, R. Valenta, T. Werfel |
| 14.30 | SSS13.3 | Atopic dermatitis in the older adult population: clinical characteristics, diagnostic and therapeutic challenges. T. Hubiche (Bordeaux, France), A. Taïeb |
| 14.45 | SSS13.4 | Proactive and reactive treatment approaches for atopic dermatitis – evidence and gut feelings. A. Wollenberg (Munich, Germany) |
| 15.00 | Questions & answers |
SSS20 Global Dermatology: Making a Difference (ISD)
14.00 – 18.00 Hall G
Chairs: U. Wollina (Dresden, Germany), J. Hercogova (Prague, Czech Republic), A. Giannetti (Modena, Italy)
| SSS20.1 | Pellagra – An Indian Rural and Urban Dermatological Issue. S. Verma (India) (Shyam B. Verma – India) |
| SSS20.2 | Community Dermatology. R. Estrada (Mexico) |
| SSS20.3 | Dermatology in Iran. Y. Dowlati (Iran) |
| SSS20.4 | Dermatology in Ethiopia. A. Morrone (Italy/Ethiopia) |
| SSS20.5 | Regional Dermatology Training Centre – Moshi. H. Grossman (Germany/Tanzania) |
| SSS20.6 | Volunteer opportunities. AAD Speaker TBA |
| SSS20.7 | ISD Updates T. Lotti (Italy) News from ISD. Regional Meetings. X ICD Update. J Hercogova (Czech Republic) 1. Call for Abstracts. 2. Scholarship Opportunities. 3. Sister Society Participation. 4. Exhibitor News. Education Scholarships. E. Handog (Philippines) Maria Duran Committee. E. Handog (Philippines Journal. L. Gibson (USA) Membership. M. Davis (USA) |
SSS21 The Telederm.org platform & Leader Network in Teledermatology (IST)
14.00 – 16.00 Hall L
Chairs: H.P. Soyer (Graz, Austria), L. Witkamp (Amsterdam, Netherlands)
SSS7 Clinical cases of Psychodermatology (ESDaP)
15.00 – 18.00 Hall F2
Chairs: K. Taube (Halle, Germany), L. Tomas (Saragoza, Spain)
| 15.00 | Welcome and opening remarks. L. Tomas (Spain) | |
| 15.10 | SSS7.1 | Two cases of psychogenic purpura. O.L. Ivanov, A.N. Lvov, A.A. Khaldin, S.S. Polunina, A.V. Michenko (Russia) |
| 15.30 | SSS7.1 | Body dysmorphic disorder. U. Gieler (Germany) |
| 15.50 | SSS7.3 | A case of dermatitis artefacta. S.E. Marron (Spain) |
| 16.10 | SSS7.4 | Environmental treatment of the skin according to psychosomatic dermatology K. Taube (Germany) |
| 16.30 | SSS7.5 | The electronic version of Skindex-29. J. de Korte (Netherlands) |
| 16.50 | SSS7.6 | A case of alopecia areata. L. Tomas (Spain) |
| 17.10 | SSS7.7 | A dysmorphophobic telepatient. D. Linder (Italy) |
| 17.30 | Discussion | |
| 17.50 | Closing remarks. K. Taube (Germany) | |
| 18.00 | Close |
SSS9 (Mohs) micrographic surgery in Europe (ESMS)
15.00 – 18.00 Hall F1
Chair: G.A.M. Krekels (Eindhoven, Netherlands)
| 15.00 | Welcome by the President of the ESMS, G.A.M. Krekels (Netherlands) | |
| 15.10 | SSS9.1 | Mohs micrographic surgery versus excision for BCC of the face. 5 Years follow up. N. Kelleners-Smeets (Maastricht, Netherlands) |
| 15.40 | SSS9.2 | Micrographic surgery for non-melanoma skin cancer. M. Möhrle (Munich, Germany) |
| 16.10 | SSS9.3 | Mohs micrographic surgery for Squamous Cell Carcinoma. S. Caers (Antwerp, Netherlands) |
| 16.30 | OGM and registration of new ESMS members |
SSS14 Euromelanoma 2007 - Update
15.00 – 17.00 Hall M
Chair: A. Katsambas (Athens, Greece)
Co-Chairs: A. Stratigos (Athens, Greece), T. Maselis (Tienen, Belgium)
Welcome address. A. Katsambas (Athens, Greece)
| SSS14.1 | A formal analysis of the Belgian Euromelanoma Campaign. V. del Marmol (Brussels, Belgium) |
| SSS14.2 | Result presentation from participating countries. TBA |
| SSS14.3 | The Euromelanoma Campaign and future perspectives. A. Stratigos (Athens, Greece) |
| SSS14.4 | Implementation of Euromelanoma-day in the federal skin day in Germany. R. Blumenthal, K. Fritz (Germany) |
| Adjournment |
SSS2 Clinical dermatology-case presentations (CEEDVA)
16.00 – 18.00 Hall L
Chairs: A.Rubins (Riga, Latvia), P.Arenberger (Prague, Czech Republic), A.Górkiewicz-Petkow (Warsaw, Poland), N.Tsankov (Sofia, Bulgaria)
